论文信息 - Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events? - 字舞流文

Is antifibrinolytic drug use in liver transplantation associated with an increased risk of thromboembolic events?

M. Abecassis | A. Wolf

[1] H. Groen,et al. Efficacy and Safety of Antifibrinolytic Drugs in Liver Transplantation: A Systematic Review and Meta‐Analysis , 2007, American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons.

[2] W. Bechstein,et al. EFFECT OF APROTININ ON INTRAOPERATIVE BLEEDING AND FIBRINOLYSIS IN LIVER TRANSPLANTATION , 1989, The Lancet.

[3] T. Starzl,et al. Epsilon‐aminocaproic Acid for Treatment of Fibrinolysis during Liver Transplantation , 1987, Anesthesiology.

[4] R Kono,et al. Antibody titres to enterovirus type 70 in the 1981 Indian epidemic of acute haemorrhagic conjunctivitis. , 1981, Lancet.

[5] D. Purtilo,et al. EPSILON-AMINOCAPROIC ACID IN HÆMATURIA , 1975, The Lancet.